Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Hepatitis associated with Kava, a herbal remedy for anxiety.

Escher M, Desmeules J, Giostra E, Mentha G.

BMJ. 2001 Jan 20;322(7279):139. No abstract available. Erratum in: BMJ 2001 May 5;322(7294):1097.

2.

Kava-kava and anxiety: growing knowledge about the efficacy and safety.

Bilia AR, Gallon S, Vincieri FF.

Life Sci. 2002 Apr 19;70(22):2581-97. Review.

PMID:
12269386
3.

Kava kava: examining new reports of toxicity.

Clouatre DL.

Toxicol Lett. 2004 Apr 15;150(1):85-96. Review.

PMID:
15068826
4.

[Weighing the efficacy and safety of herbal medicine: the case of Kava-Kava].

Ben-Arye E, Reshef A, Berry E.

Harefuah. 2004 Aug;143(8):592-7, 621. Review. Hebrew.

PMID:
15523813
5.

Kava consumption and its health effects.

Gounder R.

Pac Health Dialog. 2006 Sep;13(2):131-5. Review.

PMID:
18181402
6.

The poisoning of 'awa: the non-traditional use of an ancient remedy.

O'Sullivan HM, Lum K.

Pac Health Dialog. 2004 Sep;11(2):211-5. Review.

PMID:
16281702
7.

Anesthetic considerations of the herbal, kava.

Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE.

J Clin Anesth. 2004 Jun;16(4):305-11. Review.

PMID:
15261327
8.

Three herbs you should get to know.

Waddell DL, Hummel ME, Sumners AD.

Am J Nurs. 2001 Apr;101(4):48-53; quiz 54. Review. No abstract available.

PMID:
11301684
9.

Recognizing drug-induced liver injury: current problems, possible solutions.

Lee WM, Senior JR.

Toxicol Pathol. 2005;33(1):155-64. Review.

10.

Herb-drug interactions: interactions between kava and prescription medications.

Bressler R.

Geriatrics. 2005 Sep;60(9):24-5. Review.

PMID:
16153141
11.

Kava hepatotoxicity: a European view.

Teschke R, Schwarzenboeck A, Akinci A.

N Z Med J. 2008 Oct 3;121(1283):90-8. Review.

PMID:
18841189
12.

Therapeutic potential of kava in the treatment of anxiety disorders.

Singh YN, Singh NN.

CNS Drugs. 2002;16(11):731-43. Review.

PMID:
12383029
13.

[Kava, kavapyrones and toxic liver injury].

Teschke R.

Z Gastroenterol. 2003 May;41(5):395-404. Review. German.

PMID:
12772052
14.

Kava update: a European perspective.

Ernst E.

N Z Med J. 2004 Nov 5;117(1205):U1143. Review. No abstract available.

PMID:
15570327
15.

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.

Ernst E.

Ann Intern Med. 2002 Jan 1;136(1):42-53. Review. Erratum in: Ann Intern Med 2003 Jan 7;138(1):79.

PMID:
11777363
16.

Risks of herbal medicinal products.

Ernst E.

Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):767-71. Review.

PMID:
15386721
17.

[Acute hepatitis due to ingestion of Teucrium chamaedrys infusions].

Pérez Alvarez J, Sáez-Royuela F, Gento Peña E, López Morante A, Velasco Osés A, Martín Lorente J.

Gastroenterol Hepatol. 2001 May;24(5):240-3. Review. Spanish.

PMID:
11412592
18.

Kava.

[No authors listed]

Lancet. 1988 Jul 30;2(8605):258-9. Review. No abstract available.

PMID:
2899241
Items per page

Supplemental Content

Write to the Help Desk